KLOW 80mg

Description

DESCRIPTION

KLOW 80mg is a multi-component research blend combining KPV, GHK-Cu, BPC-157, and TB-500 (Thymosin Beta-4 fragment) in a single lyophilized preparation. Each constituent peptide interacts with distinct molecular pathways studied in laboratory models: KPV is examined for its interaction with melanocortin-associated signaling, GHK-Cu for copper-ion coordination and matrix-associated gene expression, BPC-157 for cytoprotective and angiogenic signaling cascades, and TB-500 for actin-binding and cytoskeletal dynamics.

RESEARCH AREAS

• Melanocortin pathway research — studied for KPV tripeptide interaction with NF-κB modulation in cell-culture models.
• Copper-peptide coordination chemistry — investigated for GHK-Cu extracellular matrix gene-expression signaling activity.
• Angiogenic signaling research — characterized for BPC-157 associated VEGFR and nitric-oxide pathway activity in vitro.
• Cytoskeletal dynamics research — studied for TB-500 actin-sequestration and cytoskeletal regulation mechanisms.

WHAT RESEARCHERS LOOK AT

• Reconstitution stability and component co-solubility of the multi-peptide blend under varied buffer conditions.
• Analytical separation and quantitation of individual constituents by RP-HPLC and mass spectrometry.
• Comparative pathway-marker assays isolating each peptide’s signaling contribution in vitro.
• Lot-to-lot identity confirmation and aggregation profiling of the lyophilized mixture.

QUICK SPECS

• Form: Lyophilized powder
• Net per vial: 80mg total (KPV 10mg / GHK-Cu 50mg / BPC-157 10mg / TB-500 10mg)
• Purity: ≥98% per component (HPLC)
• Identity: MS-verified (per COA)
• Storage: -20°C, protect from light; reconstituted material refrigerated and used promptly

IDENTITY BASICS

• Type: Multi-peptide research blend (four constituents)
• Sequences: KPV (Lys-Pro-Val); GHK-Cu (Gly-His-Lys·Cu²⁺); BPC-157 (Gly-Glu-Pro-Pro-Pro-Gly-Lys-Pro-Ala-Asp-Asp-Ala-Gly-Leu-Val); TB-500 (Ac-LKKTETQ fragment)
• Molecular weights: KPV ~342.4 Da; GHK-Cu ~340.9 Da; BPC-157 ~1419.5 Da; TB-500 ~889 Da
• CAS: KPV 67727-97-3; GHK-Cu 49557-75-7; BPC-157 137525-51-0; TB-500 77591-33-4

SELECTED RESEARCH

• KPV tripeptide signaling research: https://pubmed.ncbi.nlm.nih.gov/22664496/
• GHK-Cu copper peptide — PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/Copper-Tripeptide-1
• BPC-157 — PubChem: https://pubchem.ncbi.nlm.nih.gov/compound/9941957
• Thymosin Beta-4 actin-binding research: https://pubmed.ncbi.nlm.nih.gov/22636533/

Researchers may also reference BPC-157 10mg or GHK-Cu 50mg for individual component research.

⚠️ DISCLAIMER

• This product is intended for laboratory research use only.
• Not for human or veterinary use.
• Not approved for diagnostic, therapeutic, or medical applications.
• Handle using appropriate laboratory safety procedures and personal protective equipment.